As indications of impairment were identified, impairment tests were carried out for the investments. However, the tests did
not indicate a need for write-downs. The key assumptions for the tests are described below. As at 31 December 2021, no
indicators of impairment were identified for the investments in the other subsidiaries, i.e., TGE and GPWB.
Impairment test of investment in BondSpot S.A.
In 2020, the key factor impacting the financial position of the company was the situation on the Treasury bond market.
Treasury bond yields were falling sharply for the greater part of 2020, i.e., from the outbreak of the SARS-CoV-2 pandemic.
The initial withdrawal of capital from bond funds combined with actions taken by the NBP to offset the market changes led
at the turn of 2020 and 2021 to a change in the trend in the prices/yields of Polish Treasury bonds. 10-year bond yields
were rising steadily from the beginning of 2021, in line with rising yields of government bonds in foreign markets. The
increased volatility was underpinned by rising inflation expectations and investor sentiment in the market from the beginning
of 2021. Inflationary pressure, supported by rising fuel prices on global markets, proved to be a significant factor supporting
the increase in yields of Polish Treasury securities. As a direct result of those factors, turnover on the Treasury BondSpot
Poland market increased and so did the revenues of BondSpot S.A.
The goodwill impairment test based on a DCF valuation of the company was prepared on the basis of the forecast results of
BondSpot in the years 2022-2026. The main assumptions of the test performed as at 31 December 2021:
average annual revenue growth in the period 2022-2026 of 16.6%,
average annual growth in expenses in the period 2022-2026 of 4.5%,
weighted average cost of capital of 7.66%,
growth rate after 2026 equal to 2%.
The test showed that despite the update of the forecast, the recoverable amount of BondSpot S.A. determined using the
financial position as at 31 December 2021 amounting to PLN 34.4 million. Therefore, the investment in BondSpot S.A. was
not found to be impaired as at 31 December 2021. The impairment test analysis indicates that a 1.1 percentage point
decrease in the average annual revenue growth rate or a 1.5 percentage point increase in the weighted average cost of
capital or a 1.9 percentage point decrease in the growth rate after 2026 will result in the carrying amount being equal to
recoverable amount of the shares.
Impairment test of investment in GPW Tech S.A.
Due to the delay in the commencement of full operations at GPW Tech, indications of an impairment test of the investment
were identified as at 31 December 2021. The impairment test of the investment based on a DCF valuation of the company
was prepared on the basis of the projected results of GPW Tech S.A. in 2022-2026.
The main assumptions of the test performed as at 31 December 2021:
average annual revenue growth in the period 2022-2026 of 63.4%,
average annual growth in expenses in the period 2022-2026 of 26%,
weighted average cost of capital of 15.96%,
growth rate after 2026 equal to 2%.
The test showed that the recoverable amount of GPW Tech determined using the DCF method is higher than the value of the
cial position as at 31 December 2021
amounting to PLN 3.7 million. Therefore, the investment in GPW Tech S.A. was not found to be impaired as at 31 December
2021. The impairment test analysis indicates that a 2.0% decrease in the average annual revenue growth rate or a 1.2
percentage point increase in the weighted average cost of capital or a 1.2 percentage point decrease in the growth rate after
2026 will result in the carrying amount being equal to recoverable amount of the shares.
Impairment test of investment in GPW Ventures S.A.
Due to the delay in the signing of the agreement with KOWR, indications of an impairment test of the investment were
identified as at 31 December 2021. The impairment test of the investment based on a DCF valuation of the company was
prepared on the basis of the projected results of GPW Ventures S.A. in 2022-2026.
The main assumptions of the test performed as at 31 December 2021:
average annual revenue growth in the period 2022-2026 of 45.6%,
average annual growth in expenses in the period 2022-2026 of 8.5%,
weighted average cost of capital of 18.9%,
growth rate after 2026 equal to 2%.